首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿西维辛或谷胱甘肽降低顺铂引起的肾脏毒性和顺铂-DNA加合物在鼠肾脏中的水平(英文)
引用本文:张治华,Marie H HANIGAN.阿西维辛或谷胱甘肽降低顺铂引起的肾脏毒性和顺铂-DNA加合物在鼠肾脏中的水平(英文)[J].中国药理学与毒理学杂志,2004,18(2):141-145.
作者姓名:张治华  Marie H HANIGAN
作者单位:Laboratory of Cellular Carcinogenesis and Tumor Promotion,Department of Cell Biology,Laboratory of Cellular Carcinogenesis and Tumor Promotion National Cancer Institute,Bethesda,MD,208924255,University of Oklahoma Health Sciences Center,P.O.Box26901,Oklahoma City,OK73190,National Cancer Institute,Bethesda,MD,208924255
摘    要:目的 为了了解阿西维辛 (acivicin)和GSH预防肾脏毒性的机制 ,研究了顺铂 DNA加合物在大鼠肾脏中的水平。方法 顺铂 (6mg·kg- 1)从尾静脉注入大鼠 ,5d后处死。其他两组动物在给顺铂前2 .5h ,给予阿西维辛或者GSH。测量顺铂 DNA加合物在肾脏中的浓度、血中尿素氮 (BUN)和丝氨酸肌酸的浓度。结果 在给顺铂前 2 .5h ,给 10mg·kg- 1阿西维辛完全阻断了顺铂引起的肾脏毒性。具体表现是血氮和肌酸浓度降低 ,DNA加合物减少了17.1% (P <0 .0 5 )。在给顺铂前 ,给 5 0 0mg·kg- 1GSH ,肾脏毒性和顺铂 DNA加合物水平均显著性减低 (P <0 .0 5 )。另外 ,在DNA加合物和血氮之间存在着一个弱正相关关系。结论 DNA加合物在顺铂引起的肾脏毒性中引了一些作用。但是DNA加合物和血氮之间的弱相关关系提示DNA加合物与肾脏毒性只有较弱的联系 ,在顺铂引起的肾脏毒性中不是主要因素

关 键 词:DNA加合物  顺铂  谷胱甘肽  毒性  阿西维辛
收稿时间:2003-11-3

Cisplatin-DNA adduct formation in kidneys of cisplatin-exposed ratsprotected from nephrotoxicity by acivicin or glutathione
ZHANG Zhi-Hua, Marie H HANIGAN, Miriam C POIRIER.Cisplatin-DNA adduct formation in kidneys of cisplatin-exposed ratsprotected from nephrotoxicity by acivicin or glutathione[J].Chinese Journal of Pharmacology and Toxicology,2004,18(2):141-145.
Authors:ZHANG Zhi-Hua  Marie H HANIGAN  Miriam C POIRIER
Institution:1. Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, MD,20892-4255
2. Department of Cell Biology, University of Oklahoma Health Sciences Center, P.O.Box 26901, Oklahoma City, OK 73190
Abstract:AIM In order to examine the mechanisms by which these compounds prevent the development of nephrotoxicity, we investigated cisplatin-DNA adduct formation in kidneys of rats given either cisplatin alone or pretreatments with acivicin or GSH. METHODS Rats were given cisplatin 6 mg&#8226;kg-1 body weight by tail vein injection and sacrificed 5 days later. RESULTS Pretreatment with acivicin 10 mg&#8226;kg-1 body weight 2.5 h before the cisplatin completely blocked cisplatin-induced nephrotoxicity, as determined by blood urea nitrogen(BUN) and serine creatinine, and reduced renal DNA adducts by 17.1% (not statistically significant). Pretreatment with GSH 500 mg&#8226;kg-1 body weight significantly educed nephrotoxicity and lowered cisplatin-DNA adduct levels by 45.2% (P<0.05). In addition, a weakly-positive linear relationship was observed between cisplatin-DNA adducts and BUN level (r=0.47, P=0.03), and adducts and serum creatinine level (r=0.50, P=0.02). CONCLUSION The associations observed between cisplatin-DNA adduct levels and these nephrotoxic end points suggest that cisplatin-DNA adducts or their correlates be only weakly associated with kidney damage. The lack of strong associations here supports the conclusion that cisplatin-DNA adducts are not the major cause of cisplatin-induced kidney toxicity.
Keywords:DNA adducts  cisplatin  glutathione  toxicity  acivicin
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国药理学与毒理学杂志》浏览原始摘要信息
点击此处可从《中国药理学与毒理学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号